This video examines results of a study that looked at treatment tolerability in elderly patients with HPV-positive oropharyngeal squamous cell carcinoma.
In this video, Richard Bakst, MD, of the Icahn School of Medicine at Mount Sinai in New York, discusses a study that examined treatment tolerability and outcomes in elderly patients (65 years and older) with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma.
Bakst presented the results of the study (abstract 2764) at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, held September 24–27 in San Diego.
Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer
March 5th 2024Patients with factors such as lymphovascular space invasion or positive glossectomy specimen margins may be considered for adjuvant radiotherapy to optimize disease control of tongue squamous cell carcinoma.